HUP0301386A2 - Enterálisan beadandó kiegészítż táplálék kritikus állapotban lévż betegek, krónikus betegségekben szenvedż vagy alultáplált személyek parenterális táplálására vagy részleges enterális/orális táplálására - Google Patents

Enterálisan beadandó kiegészítż táplálék kritikus állapotban lévż betegek, krónikus betegségekben szenvedż vagy alultáplált személyek parenterális táplálására vagy részleges enterális/orális táplálására

Info

Publication number
HUP0301386A2
HUP0301386A2 HU0301386A HUP0301386A HUP0301386A2 HU P0301386 A2 HUP0301386 A2 HU P0301386A2 HU 0301386 A HU0301386 A HU 0301386A HU P0301386 A HUP0301386 A HU P0301386A HU P0301386 A2 HUP0301386 A2 HU P0301386A2
Authority
HU
Hungary
Prior art keywords
nutrition
ill
malnutrition
supplement
people
Prior art date
Application number
HU0301386A
Other languages
English (en)
Inventor
Barbara Kessler
Angelika Riedel
Ulrich Suchner
Original Assignee
Fresenius Kabi Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland Gmbh. filed Critical Fresenius Kabi Deutschland Gmbh.
Publication of HUP0301386A2 publication Critical patent/HUP0301386A2/hu
Publication of HUP0301386A3 publication Critical patent/HUP0301386A3/hu
Publication of HU228351B1 publication Critical patent/HU228351B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya enterálisan beadandó kiegészítő táplálék a bélgátmegőrzésére vagy helyreállítására kritikus állapotban lévő vagykrónikus betegeknél, továbbá alultáplált személyeknél. A találmányszerinti kiegészítő táplálék a napi dózisra vonatkoztatva a) 15-70 gglutamint és/vagy glutamin-elővegyületet, b) antioxidáns hatástkifejtő anyagok legalább két képviselőjét, és c) rövid szénláncúzsírsavak és/vagy rövid szénláncú zsírsavak elővegyületeinek 0,5-10 gmennyiségét tartalmazza oldatban. Ó
HU0301386A 2000-11-17 2001-11-14 Enterálisan beadandó kiegészítõ táplálék és alkalmazása kritikus állapotban lévõ betegek, krónikus betegségekben szenvedõ vagy alultáplált személyek parenterális táplálására vagy részleges enterális/orális táplálására HU228351B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10057290A DE10057290B4 (de) 2000-11-17 2000-11-17 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
PCT/EP2001/013163 WO2002039978A1 (de) 2000-11-17 2001-11-14 Enteral zu verabreichendes supplement zur parenteralen ernährung oder partiellen enteralen/oralen ernährung bei kritisch kranken, chronisch kranken und mangelernährten

Publications (3)

Publication Number Publication Date
HUP0301386A2 true HUP0301386A2 (hu) 2003-09-29
HUP0301386A3 HUP0301386A3 (en) 2008-04-28
HU228351B1 HU228351B1 (hu) 2013-03-28

Family

ID=7663817

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301386A HU228351B1 (hu) 2000-11-17 2001-11-14 Enterálisan beadandó kiegészítõ táplálék és alkalmazása kritikus állapotban lévõ betegek, krónikus betegségekben szenvedõ vagy alultáplált személyek parenterális táplálására vagy részleges enterális/orális táplálására

Country Status (28)

Country Link
US (1) US7947303B2 (hu)
EP (1) EP1337236B1 (hu)
JP (1) JP2004513912A (hu)
KR (2) KR20080069280A (hu)
CN (1) CN1477950A (hu)
AT (1) ATE272390T1 (hu)
AU (2) AU2002224848B2 (hu)
BR (1) BRPI0115451B1 (hu)
CA (1) CA2429270C (hu)
CZ (1) CZ300129B6 (hu)
DE (2) DE10057290B4 (hu)
DK (1) DK1337236T3 (hu)
EE (1) EE05209B1 (hu)
ES (1) ES2223015T3 (hu)
HR (1) HRP20030395B1 (hu)
HU (1) HU228351B1 (hu)
IL (2) IL155840A0 (hu)
IS (1) IS2377B (hu)
MX (1) MXPA03004348A (hu)
NO (1) NO333003B1 (hu)
NZ (1) NZ525812A (hu)
PL (1) PL202031B1 (hu)
PT (1) PT1337236E (hu)
RU (1) RU2295952C2 (hu)
SI (1) SI1337236T1 (hu)
SK (1) SK286199B6 (hu)
WO (1) WO2002039978A1 (hu)
ZA (1) ZA200303722B (hu)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
WO2005023274A1 (en) * 2003-09-05 2005-03-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
US20070225203A1 (en) * 2003-09-19 2007-09-27 N.V. Nutricia Method and Composition for Preventing Multiple Organ Dysfunction Syndrome
DE10349585A1 (de) * 2003-10-24 2005-06-16 Biosyn Arzneimittel Gmbh Spurenelementzusammensetzung für die Ernährung
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use
RU2433819C2 (ru) * 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Применение антиоксидантов для модуляции генов
CN101084003A (zh) * 2004-12-21 2007-12-05 重症救护联络公司 治疗性营养组合物或联合药物及其使用方法
AU2006240560B2 (en) 2005-04-27 2011-10-27 N.V. Nutricia Nutrition with lipids and non-digestible saccharides
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
US20090104705A1 (en) * 2005-05-23 2009-04-23 Jan Frederik Stevens Ascorbic acid conjugates
JP2009506012A (ja) 2005-08-26 2009-02-12 ネステク ソシエテ アノニム 肥満患者の栄養素
DE102005046237A1 (de) * 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
US20090312427A1 (en) * 2005-11-15 2009-12-17 Entress Ab Medicament for Use in Connection With Cartilage Impairment
EP1971230A2 (en) * 2006-01-09 2008-09-24 Nestec S.A. Treatment of stressed patients
US20100215631A1 (en) * 2006-06-14 2010-08-26 Anita Hartog Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
KR100774816B1 (ko) * 2006-11-21 2007-11-07 동부일렉트로닉스 주식회사 반도체 소자의 ｍｉｍ 커패시터 제조 방법 및 구조
BRPI0816993A2 (pt) * 2007-09-17 2014-10-07 Nutricia Nv Uso de uma composição, e, composição nutricional
EP2205235A4 (en) * 2007-10-14 2010-11-17 Univ Florida PREPARATION TO IMPROVE GASTROINTESTINAL FUNCTION
IT1396935B1 (it) * 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
US20130210715A1 (en) * 2010-04-26 2013-08-15 Nestec S.A. Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition
US20140030241A1 (en) * 2011-03-31 2014-01-30 Nestec S.A. Nutritional compositions for increasing arginine levels and methods of using same
KR20180100455A (ko) * 2011-04-13 2018-09-10 아지노모토 가부시키가이샤 영양 조성물
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
BR112017026185A2 (pt) 2015-06-10 2018-08-14 Ajinomoto Kk agente e método para melhorar um distúrbio gastrointestinal induzido por exercício.
ES2638195B1 (es) * 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
CA3062798A1 (en) 2017-05-09 2018-11-15 Baxter International Inc. Parenteral nutrition diagnostic system, apparatus, and method
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation
DE202021102589U1 (de) 2020-12-15 2021-05-28 Marco Lautenschläger Verzehrfertiges, abgefülltes Getränk auf Basis eines natürlichen Mineralwassers
WO2023205635A1 (en) * 2022-04-19 2023-10-26 Vanderbilt University Compositions and methods of treatment for congenital diarrheal disorder
WO2023215458A1 (en) * 2022-05-06 2023-11-09 Ageless Sciences, Inc. Compositions and methods for slowing down aging and extending lifespan
CN116920075B (zh) * 2023-09-15 2024-01-02 潍坊市人民医院(潍坊市公共卫生临床中心) 一种肠内营养液及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
DE3135849A1 (de) * 1981-09-10 1983-03-17 Dr. Schumacher GmbH & Co KG, 4600 Dortmund Beschichtungsstoff fuer korrosionsschutzzwecke
US4446389A (en) * 1982-03-15 1984-05-01 Ampex Corporation Quadrature tach decoder circuit
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JP2524551B2 (ja) * 1992-02-28 1996-08-14 雪印乳業株式会社 グルタミン含量の高いペプチド組成物、その製造方法及び経腸栄養剤
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
ES2173109T3 (es) * 1992-12-23 2002-10-16 Abbott Lab Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas.
JP4059532B2 (ja) * 1994-08-15 2008-03-12 森永乳業株式会社 腸内細菌の体内移行を阻止するペプチド混合物と、このペプチド混合物を含有する組成物
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP4011638B2 (ja) * 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH09323979A (ja) * 1996-06-04 1997-12-16 Meiji Milk Prod Co Ltd 核酸を用いた免疫調節組成物
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
WO1998041216A1 (en) * 1997-03-17 1998-09-24 Tam Yun K Composition for prevention of hepatic steatosis
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AU2186699A (en) * 1998-02-09 1999-08-23 Meiji Milk Products Co., Ltd. Preventives and remedies for intestinal mucosal disorder
US6369252B1 (en) * 1998-02-26 2002-04-09 The University Of Georgia Research Foundation, Inc. Structured lipids
CA2343790A1 (en) * 1998-09-11 2000-03-23 Cultor Food Science, Inc. Reduced calorie plastic fat composition
JP2000119180A (ja) * 1998-10-06 2000-04-25 Nisshin Flour Milling Co Ltd 経腸栄養剤
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives

Also Published As

Publication number Publication date
RU2295952C2 (ru) 2007-03-27
CZ300129B6 (cs) 2009-02-18
EE200300198A (et) 2003-08-15
KR100861889B1 (ko) 2008-10-09
DE10057290B4 (de) 2004-01-08
CA2429270C (en) 2009-08-18
BRPI0115451B1 (pt) 2016-07-19
CA2429270A1 (en) 2002-05-23
SK286199B6 (sk) 2008-05-06
DE10057290A1 (de) 2002-06-06
JP2004513912A (ja) 2004-05-13
PT1337236E (pt) 2004-11-30
NO20032160L (no) 2003-07-14
EP1337236A1 (de) 2003-08-27
IS6815A (is) 2003-05-14
PL361634A1 (en) 2004-10-04
AU2002224848B2 (en) 2006-06-15
HU228351B1 (hu) 2013-03-28
CN1477950A (zh) 2004-02-25
ATE272390T1 (de) 2004-08-15
CZ20031337A3 (cs) 2003-09-17
EP1337236B1 (de) 2004-08-04
KR20030069172A (ko) 2003-08-25
MXPA03004348A (es) 2003-08-19
IL155840A (en) 2008-11-03
EE05209B1 (et) 2009-10-15
SK5612003A3 (en) 2003-10-07
US7947303B2 (en) 2011-05-24
NZ525812A (en) 2004-03-26
WO2002039978A8 (de) 2002-07-18
IL155840A0 (en) 2003-12-23
SI1337236T1 (en) 2004-12-31
ZA200303722B (en) 2004-04-16
DE50103152D1 (de) 2004-09-09
KR20080069280A (ko) 2008-07-25
HRP20030395A2 (en) 2005-04-30
ES2223015T3 (es) 2005-02-16
DK1337236T3 (da) 2004-12-13
NO333003B1 (no) 2013-02-11
US20040097404A1 (en) 2004-05-20
IS2377B (is) 2008-07-15
WO2002039978A1 (de) 2002-05-23
AU2484802A (en) 2002-05-27
HRP20030395B1 (en) 2011-10-31
NO20032160D0 (no) 2003-05-13
HUP0301386A3 (en) 2008-04-28
PL202031B1 (pl) 2009-05-29
BR0115451A (pt) 2004-01-06

Similar Documents

Publication Publication Date Title
HUP0301386A2 (hu) Enterálisan beadandó kiegészítż táplálék kritikus állapotban lévż betegek, krónikus betegségekben szenvedż vagy alultáplált személyek parenterális táplálására vagy részleges enterális/orális táplálására
AU2002224848A1 (en) Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
MY144565A (en) Use of glutamate or of glutamic acid for the prevention of hyperpermeability or undesired permeability of the intestinal wall
MX9205722A (es) Composicion alimenticia enteral contra el cancer
Kulkarni et al. L-Glutamic acid and glutamine: Exciting molecules of clinical interest
MXPA05003732A (es) Metodos y composiciones para proporcionar glutamina.
BR112012009380A2 (pt) intestino e a recuperação muscular
IS2234B (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
Chung Nutrition support methods in elderly patients
PL355200A1 (en) Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms
Gündoğan et al. Malnutrition in Intensive Care Units: An Important Risk Factor for Intensive Care Unit-Acquired Infections.
RU2012156681A (ru) Средство (варианты), фармацевтическая композиция и способ химиопрофилактики предрака и рака предстательной железы
PL425242A1 (pl) Zastosowanie 3'-amino-4-karboksychalkonu
BR112023004232A2 (pt) Composições contendo nicotinamida e vitamina b6 e métodos de uso de tais composições para tratar sarcopenia e debilidade
PL425235A1 (pl) Zastosowanie izoksantohumolu
Vaisrub An element of pleasure
Boggio Scurvy in a 10-month-old boy
Pittler et al. Sample size and study interpretation
JO2496B1 (en) A dietary supplement containing a range of anticancer, fatty acids, proteins and essential vitamins to prevent and treat cancer

Legal Events

Date Code Title Description
NF4A Restoration of patent protection
MM4A Lapse of definitive patent protection due to non-payment of fees